
"The data show that treatment with pembrolizumab and chemotherapy together is more effective than chemotherapy alone", said lead investigator Leena Gandhi, director of the thoracic medical oncology program at Perlmutter Cancer Center at NYU Langone Health.
Chicago: For the first time, a treatment that boosts the immune system greatly improved survival in people newly diagnosed with the most common form of lung cancer.
Herbst said medical researchers didn't immediately think of combining chemotherapy with immunotherapy because it seemed odd to try to use chemicals to kill the cancer cells that the immune system was also supposed to be hunting down.
The new studies suggest that different types of tumors should receive different treatment regimens, all including immune therapy, Hellmann said.
Dr. Jorge Gomez, a volunteer spokesperson for the American Lung Association and a medical oncologist and director of thoracic oncology at Mount Sinai Hospital in NY, explained that "about 220,000 patients are diagnosed with lung cancer a year in the United States". The studies simultaneously were published by the New England Journal of Medicine on a day that some experts called the Super Bowl of lung cancer immunotherapy..
But trials over the last five years have repeatedly shown more uses for immune therapy in lung cancer, and the new research confirms that almost all lung cancer patients will now receive immune therapy, said Patrick Forde, the first author on one of the studies and a lung cancer specialist at Johns Hopkins Medical. And among those in the comparison group, who got a placebo and chemotherapy, 99 percent reported side effects. Checkpoint inhibitors are one of two main types of immunotherapy. Herbst compares it with inflammation around a cut, which marshals the immune system into action, only in this case the wound being targeted is debris from dead cancer cells. He was not involved in the pembrolizumab study.
Keytruda was approved previous year as an initial treatment with chemo for the most common form of advanced lung cancer, but doctors have been leery to use it because that was based on a small study that did not show whether it prolongs life. Patients with those mutations (called EGFR and ALK) were not included in this study, and instead were referred to treatment with the drugs that target their mutation.
Lebanon Special School District Board gets new construction management
The board voted unanimously March 27 to hire Matthew Strine of Shippensburg as the new superintendent, effective July 1. Carpenter said he feels he has done nothing to cause distrust on the board, and he trusts other school board members.
Arsene Wenger Rips Premier League Over VAR Decision
Are the fans of exhausted of this season and do not care how it pans out, even if Arsenal go on to win the Europa League? As far as Arsenal are concerned, the Wenger era is running on fumes and has been for some time.
Chinese market puts a €100m slice of Irish beef on the menu
CHINA HAS OPENED its markets to Irish beef after years of negotiations, Agriculture Minister Michael Creed confirmed this morning. Mr Creed will lead a trade mission to China next month to consolidate Ireland's trading relationship with the Chinese government.
Other studies presented at the meeting also highlighted advances in immunotherapy against lung cancer, but were at earlier points in the research and less likely to bring about immediate changes in medical practice.
For the first time, adding another drug has significantly impacted the long-term outlook for those patients, she said.
Non-squamous lung cancer patients make up about 80% of all the non-small cell lung cancers, so that amounts to over 150,000 patients in the U.S. each year, said Gomez, who was not involved in the new study.
Hellmann's study, called CheckMate 227, found that advanced tumors that contain a lot of genetic mutations - often from smoking - respond particularly well to a combination of two immune therapy drugs, Yervoy and Opdivo, both from Bristol-Myers Squibb.
The other, vehicle T therapy, genetically reprograms a patient's immune T-cells to find and destroy cancer. But many doctors did not adopt it because the trial was small and didnt initially show a survival benefit, Gandhi said. The immunotherapy drugs did not help people with fewer tumor gene flaws.
After a median followup of 10.5 months, those in the immunotherapy group were half as likely to die.
The estimated survival after a year was 69 per cent in those taking the immunotherapy drugs compared to 49 per cent who only had chemotherapy.
Related News:
-
Shire sells oncology unit to Servier for $2.4bn
Hyman Charles D holds 0.03% of its portfolio in Cisco Systems, Inc. (NASDAQ:COHR). 1,250 were accumulated by Greatmark Prtnrs. Four equities research analysts have rated the stock with a hold rating and twenty have assigned a buy rating to the company.Moyes reacts to West Ham comeback and Hart's error
Marko Arnautovic had already had a header ruled out for offside when Edimilson Fernandes rifled into the net on 67 minuets. On this occasion, he was involved in three disallowed West Ham goals.Russian Ambassador to USA warns of 'consequences' for Syrian missile strike
Russian Federation has also used its United Nations veto six times to prevent condemnation of Assad's use of chemical weapons . Putin was quoted as urging for a "thorough and objective probe" into the reports of the chemical weapons attack. -
New defeat for Alfie Evans' parents in battle for treatment overseas
Alfie, from Bootle, Merseyside, has been at Alder Hey since December 2016 with an undiagnosed degenerative brain disease. Diamond indicated that he would make a direct appeal to the Supreme Court by 4 p.m. local time on Tuesday.'Night Court' actor Harry Anderson dies at home
Police confirmed the news this morning, revealing that no foul play was suspected in his death. Anderson then went on to land his most well-known role, playing Judge Harry T.Syria chemical attack staged by United Kingdom , claims Russian Federation
The western strikes on Syria are "unacceptable and lawless", according to Russia's Foreign Affairs Minister, Sergey Lavrov. The government, however, said evacuations from Douma were ongoing and no Syrian government forces had entered the town. -
Manchester City crowned Premier League champions
Not only that but he did it with five games remaining, equalling the English top-flight record of United (1907-08 and 2000-01) and Everton (1984-85).Joel Embiid 'wants green light to play' for Philadelphia 76ers
Mills' 21 points was a personal playoff record and a return to form after the struggles he suffered in game one on Saturday. The Heat halted that in game two by sending a rotation of defenders to get in Simmons' face and harass his shooters.Domino's Pizza Group (DOM) Given Consensus Rating of "Hold" by Brokerages
Balyasny Asset Limited Co owns 0.25% invested in General Motors Company (NYSE:GM) for 1.98 million shares. (NYSE:DAR). The stock of Microsoft Corporation (NASDAQ:MSFT) has "Buy" rating given on Wednesday, July 20 by Stifel Nicolaus. -
Billy Mitchell responds to Kongtroversy, claims he can prove scores were legitimate
He says he will prove his innocence; "witnesses, documents, everything will be made available". You absolutely have my commitment to that.Ian Somerhalder To Star In Netflix Series V-Wars
William Laurin and Glenn Davis, creators of the Canadian crime drama 1-800-Missing, will serve as showrunners for the series. Ian Somerhalder has locked down his next role after his hit television series The Vampire Diaries ended its run in 2017.Syrian air defences shoot down missiles in Homs
A local reporter for The Arab News said Israeli warplanes were spotted in Syrian airspace just before the missiles were reported. Reuters cited Pentagon spokesman Eric Pahon as saying that "there is no USA military activity in that area at this time".